JONES KENNETH T (See Remarks) received a stock award from ZYNERBA PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/11/2023ACC: 0001140361-23-047746
Officer· See Remarks
Since Aug 2023
-106.77K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
30K acquired · 136.77K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−40.52K
Price / share
—
Trade value
—
% of position
47.4%
10/10/2023
85.52K→45K
Common Stock
Direct
Shares
+30K
Price / share
—
Trade value
—
% of position
66.7%
10/10/2023
45K→75K
Common Stock
Direct
Shares
−75K
Price / share
—
Trade value
—
% of position
New position
10/10/2023
75K→0.00
Total
Net shares
−85.52K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/10/2023 | U · U | −40.52K | — | — | 47.4% | 85.52K | 45K |
| Common Stock Direct | 10/10/2023 | A · Award | +30K | — | — | 66.7% | 45K | 75K |
| Common Stock Direct | 10/10/2023 | U · U | −75K | — | — | New position | 75K | 0.00 |
| Total | −85.52K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
21.25K shares
Shares
−21.25K
Strike price
2.41
Held after
0.00
Exercisable
—
10/10/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock21.25K shares | 10/10/2023 | D · Disposition | −21.25K | 2.41 | — | 0.00 |